These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 457369)

  • 1. Feedback control in the management of cardiac arrhythmias.
    Collins SM; Arzbaecher RC
    ISA Trans; 1979; 18(1):95-100. PubMed ID: 457369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feedback control in the management of cardiac arrhythmias.
    Collins SM; Arzbaecher RC
    Biomed Sci Instrum; 1978 Apr 17-18; 14():157-62. PubMed ID: 687728
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of disopyramide phosphate on ventricular arrhythmias in experimental myocardial infarction.
    Kus T; Sasyniuk BI
    J Pharmacol Exp Ther; 1976 Mar; 196(3):665-75. PubMed ID: 1263118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacodynamics and pharmacokinetics of disopyramide phosphate].
    Ol'binskaia LI; Tiukavkina NA; Kuz'mina MM; Beloborodov VL; Klimov AV
    Farmakol Toksikol; 1985; 48(4):73-8. PubMed ID: 3930285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 60x computer-based Holter tape processing system.
    Hubelbank M; Feldman CL
    Med Instrum; 1978; 12(6):324-6. PubMed ID: 85243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Automated administration of lidocaine for the treatment of ventricular arrhythmias.
    Jannett TC; Kay GN; Sheppard LC
    Med Prog Technol; 1990 May; 16(1-2):53-9. PubMed ID: 1690837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intravenously disopyramide phosphate administration for treatment of arrhythmias].
    Aquaro G; Belli R; Pavia M; Rey L; Ravera A; Possavino G; Idone P
    G Ital Cardiol; 1982; 12(7):509-19. PubMed ID: 7169147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of multiple bolus loading of intravenous disopyramide.
    Simpson RJ; Foster JR; Benge C; Baker S; Gettes LS
    Am Heart J; 1983 Sep; 106(3):505-8. PubMed ID: 6881023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the new class I antiarrhythmic agent Ro 22-9194, (2R)-2-amino-N-(2,6-dimethylphenyl)-N-[3-(3-pyridyl)propyl]propionamide D-tartrate, on ischemia- and reperfusion-induced arrhythmias in dogs: involvement of thromboxane A2 synthase inhibitory activity.
    Murakami M; Kinukawa M; Kanazawa T; Maruyama K; Miyagi M; Miyata H; Ujiie A
    J Pharmacol Exp Ther; 1996 Nov; 279(2):877-83. PubMed ID: 8930195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Technical characteristics of a new computerized system for quantitative evaluation of cardiac arrhythmias (author's transl)].
    Leclercq JF; Attuel P; Coumel P
    Anesth Analg (Paris); 1979; 36(9-10):467-70. PubMed ID: 533006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sudden cardiac death--an approach to management of the patient at risk.
    Podrid PJ; Blatt CM
    Herz; 1984 Apr; 9(2):65-76. PubMed ID: 6714916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Value of a computerized system of real time analysis of arrhythmias in the intensive care unit. Description of the ATREC system].
    Dupays M; Jammal M; Zoute Y; Assemann P; Thery C
    Ann Cardiol Angeiol (Paris); 1983; 32(1):47-54. PubMed ID: 6688164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term drug therapy of arrhythmias (with special reference to ventricular tachyarrhythmias].
    Gertsch M
    Schweiz Med Wochenschr; 1984 Jan; 114(3):77-86. PubMed ID: 6199838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Quantitative evaluation of an antiarrhythmic therapy (disopyramide) in patients with frequent premature ventricular contractions (PVC) using a computer-assisted long-term ECG analysis system (author's transl)].
    Weber H; Gloger D; Joskowicz G; Steinbach K
    Z Kardiol; 1981 Jan; 70(1):13-21. PubMed ID: 7210773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the antiarrhythmic efficacy of mexiletine in patients with chronic ventricular arrhythmias.
    Van Durme JP
    Acta Cardiol Suppl; 1980; (25):121-5. PubMed ID: 6990664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term use of controlled-release disopyramide in patients with severe ventricular arrhythmias.
    Paulk EA
    Angiology; 1987 Feb; 38(2 Pt 2):198-204. PubMed ID: 3103494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics, antiarrhythmic effects, and tissue concentrations of amiodarone and desethylamiodarone in dogs with acute coronary artery occlusion.
    Somani P; Simon VA; McManus K
    Can J Cardiol; 1985 Jan; 1(1):56-65. PubMed ID: 3850764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical and hemodynamic effects of disopyramide phosphate administered i.v. in cardiopathic subjects (author's transl)].
    Chiariello M; Santinelli V; Ferro G; Tari MG; Stanislao M; Condorelli M
    G Ital Cardiol; 1979; 9(9):975-83. PubMed ID: 520746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiarrhythmic effects of desethylamiodarone in dogs with subacute myocardial infarction and inducible ventricular arrhythmias.
    Abdollah H; Brien JF; Brennan FJ
    J Cardiovasc Pharmacol; 1989 Jan; 13(1):37-44. PubMed ID: 2468934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dual-processor computer for arrhythmia analysis.
    Kinias P; Norusis M; Fozzard HA
    Med Instrum; 1978; 12(6):330-1. PubMed ID: 85244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.